MedPath

A study to compare the effect of virechana karma (purgation therapy) to standard treatment in the management of Non-Alcoholic Fatty Liver Disease (Yakritodara).

Phase 3
Conditions
Health Condition 1: K758- Other specified inflammatory liverdiseases
Registration Number
CTRI/2023/05/052432
Lead Sponsor
Ayurvedic and Unani Tibbia college and hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients diagnosed with case of NAFLD grade- I/II/III by USG.

Exclusion Criteria

1) Patients who are contraindicated for virechana karma- like lower GI bleeding, Prolapse of rectum, incontinence of stool, pregnant and lactating mothers etc. will not be included in the trial group.

2) Patients taking antifungal, antibacterial, or antibiotic medication.

3) Patients with Ascites, Liver cirrhosis, Oesophageal varices, Jaundice, Cholelithiasis.

4) Patients with history of Cholecystectomy.

5) Patients requiring emergency treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath